[
  {
    "ts": null,
    "headline": "Labcorp Holdings (NYSE:LH) Introduces FDA-Approved Self-Collection Tests For HPV And STIs",
    "summary": "Labcorp Holdings (NYSE:LH) saw its stock price increase by 1.49% over the last quarter, possibly driven by the announcement of its FDA-approved HPV self-collection solution and STI testing option aimed at improving women's health screening. These innovations might have boosted investor confidence despite the broader market's decline and uncertainties surrounding new tariffs impacting overall economic sentiment. The company's Q4 2024 financial results, showing improved net income and EPS,...",
    "url": "https://finnhub.io/api/news?id=28e4f4d73dd5b3a2c812ef017d140fe9ab1e62157839dfd2ee6419dd860942eb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743528457,
      "headline": "Labcorp Holdings (NYSE:LH) Introduces FDA-Approved Self-Collection Tests For HPV And STIs",
      "id": 133655362,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LH",
      "source": "Yahoo",
      "summary": "Labcorp Holdings (NYSE:LH) saw its stock price increase by 1.49% over the last quarter, possibly driven by the announcement of its FDA-approved HPV self-collection solution and STI testing option aimed at improving women's health screening. These innovations might have boosted investor confidence despite the broader market's decline and uncertainties surrounding new tariffs impacting overall economic sentiment. The company's Q4 2024 financial results, showing improved net income and EPS,...",
      "url": "https://finnhub.io/api/news?id=28e4f4d73dd5b3a2c812ef017d140fe9ab1e62157839dfd2ee6419dd860942eb"
    }
  },
  {
    "ts": null,
    "headline": "Labcorp to Offer HPV and STI Self-Collection Options in Labcorp Patient Service Centers and Participating Physician Offices Nationwide",
    "summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it will offer nationwide a U.S. Food and Drug Administration (FDA) approved human papillomavirus (HPV) self-collection solution that can help women and their physicians asses the risk of developing cervical cancer. Labcorp will also offer a vaginal swab self-collect option for sexually transmitted infection (STI) testing. Both solutions are available by physician order and can be completed pr",
    "url": "https://finnhub.io/api/news?id=e590d07a21d82f278bf27496cfe7f51e9134fdb263cc3d1101d2bb3b5b4f76ce",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743510720,
      "headline": "Labcorp to Offer HPV and STI Self-Collection Options in Labcorp Patient Service Centers and Participating Physician Offices Nationwide",
      "id": 133646031,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LH",
      "source": "Yahoo",
      "summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it will offer nationwide a U.S. Food and Drug Administration (FDA) approved human papillomavirus (HPV) self-collection solution that can help women and their physicians asses the risk of developing cervical cancer. Labcorp will also offer a vaginal swab self-collect option for sexually transmitted infection (STI) testing. Both solutions are available by physician order and can be completed pr",
      "url": "https://finnhub.io/api/news?id=e590d07a21d82f278bf27496cfe7f51e9134fdb263cc3d1101d2bb3b5b4f76ce"
    }
  }
]